# Safety Study of TAK-700 in Subjects With Prostate Cancer.

> **NCT00569153** · PHASE1,PHASE2 · COMPLETED · sponsor: **Millennium Pharmaceuticals, Inc.** · enrollment: 123 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** TAK-700

## Key facts

- **NCT ID:** NCT00569153
- **Lead sponsor:** Millennium Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2013-01
- **Final completion:** 2013-02
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2016-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569153, "Safety Study of TAK-700 in Subjects With Prostate Cancer.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00569153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*